Archive for the 'Topicals and Creams' Category

Three Topical Treatments for Rosacea Compared

Friday, November 20th, 2009

In a small, randomized double-blinded study, researchers have found that azelaic acid 20% cream is as effective as metronidazole 0.75% cream and permethrin 20% cream for treating rosacea.
The study, published in the Journal of the European Academy of Dermatology and Venereology, included 24 patients (23 women, 1 man), aged 42 to 61 years, with facial [...]

New Survey Reveals How Rosacea Patients Feel About Their Treatments and Their Physicians

Friday, May 1st, 2009

A new survey of people with rosacea offers new insight into their experiences with different treatments for their skin condition and with their health care providers.
The survey was conducted in 2006 and published in a recent issue of the Journal of Drugs in Dermatology. It included more than 2,800 people with diagnosed cases of rosacea. [...]

Study Explores Contact Allergy in Rosacea Patients

Wednesday, April 15th, 2009

People with rosacea must be careful with their choices of skin-care products, as some can contain ingredients that may trigger a skin reaction and a worsening of their symptoms. Yet there is little data on contact allergy in rosacea patients.
“This is astonishing,” note the authors of a recent study on the topic in the Journal [...]

Rosacea: A High Price to Pay

Monday, July 21st, 2008

The emotional suffering rosacea may cause those who have it can be severe, but a new study also showed that the cost of rosacea to taxpayers pay also be significant. A study by Ohio State University researchers tracked 2,587 patients with rosacea prescriptions to follow their refill adherence. The study showed some interesting results. According [...]

A New Study Shows Topical S-MSM Effective in Treating Rosacea

Monday, February 11th, 2008

A new study from the San Gallicano Dermatologic Institute in Rome shows that a topical treatment based on silymarin/methylsulfonilmethane (S-MSM) can be effective in treating stage I-III rosacea patients. Drs. Berardesca et al used the topical medications on 46 patients over 30 days in a double-blind, placebo controlled study. Instrumental evaluations were done after 10 [...]